Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02873104
Other study ID # C-16-TS11
Secondary ID
Status Completed
Phase N/A
First received August 16, 2016
Last updated January 31, 2018
Start date March 2016
Est. completion date September 2016

Study information

Verified date February 2017
Source Cutera Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To evaluate the safety and efficacy of the Cutera truSculpt radiofrequency device for circumferential reduction.


Description:

The objectives of this study are to evaluate efficacy and safety of treatment with the Cutera truSculpt RF device for circumferential reduction in the abdominal and flank region.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 24 Years to 60 Years
Eligibility Inclusion Criteria:

- Female or Male, 24 to 60 years of age (inclusive). Fitzpatrick Skin Type I - VI. Has visible fat bulges on the abdomen and palpable fat pockets superior to iliac crest located bilaterally in the lower back flank region Has a Body Mass Index (BMI) = 20 and = 30 Non-smoking for at least 6 months and willing to refrain from smoking for the duration of the study.

Subject must agree to not undergo any other procedure(s) in the abdominal and flank region during the study period.

Subject must be able to read, understand and sign the Informed Consent Form. Subject must adhere to the follow-up schedule and study instructions. Subject must adhere to the same diet and/or exercise routine throughout the study, and agree to maintain the same weight throughout the study, within 5% of baseline weight measurement.

Willing to have digital photographs taken of the treatment area and agree to use of photographs for presentation, educational or marketing purposes.

Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant.

Exclusion Criteria:

- Participation in a clinical trial of another device or drug within 6 months of study participation, or during the study period.

Any type of prior cosmetic treatment to the target area within 12 months of study participation e.g., radiofrequency, cryolysis or light-based treatments.

Any prior invasive cosmetic surgery to the target area, such as liposuction. Currently taking medications or supplements for weight-loss or metabolism support/enhancement or has a history of taking such medications or supplements within 3 months.

Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve stimulator implant, cochlear implant or any other electronically, magnetically or mechanically activated implant.

Has metal implant(s) within the body, such as surgical clips, plates and screws, intrauterine device (IUD), artificial heart valves or artificial joints.

Significant concurrent illness, such as diabetes mellitus, cardiovascular disease, peripheral vascular disease or pertinent neurological disorders.

Diagnosed or documented immune system disorders. History of any disease or condition that could impair wound healing. History of diseases stimulated by heat, such as recurrent herpes zoster in the treatment area, unless treatment is conducted following a prophylactic regimen.

History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.

Infection, dermatitis, rash or other skin abnormality in the target area. Currently undergoing systemic chemotherapy or radiation treatment for cancer, or history of treatment in the target area within 3 months of study participation.

Pregnant or currently breastfeeding. As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
truSculpt rf device
radiofrequency device

Locations

Country Name City State
United States Cutera Research Center Brisbane California

Sponsors (1)

Lead Sponsor Collaborator
Cutera Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment Change in Abdominal Circumferential Measurement Related to Sham and Therapeutic Group at 12 Weeks Post-treatment minus Baseline Measurement 12 weeks
Secondary Subject Assessment of Improvement for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment. Comparison of the average subject improvement score for the sham group and the therapeutic group at 12 weeks post-treatment using a 0 - 4 improvement scale where 0 equals "no change" and 4 equals "Very Significant Improvement". 12 weeks
Secondary Subject Satisfaction Level for Both Sham Group and Therapeutic Group at 12 Weeks Post-treatment. Comparison of the average subject satisfaction level for the sham group and therapeutic group at 12 weeks post-treatment, using a 1 - 5 scale where 1 equals "very dissatisfied" and 5 equals "very satisfied". 12 weeks
Secondary Subject Discomfort and Pain Levels During Treatment Comparison of the average pain levels during treatment for the sham group and therapeutic group at 12 weeks post-treatment, using a 0 - 10 scale where 0 equals "No pain" and 10 equals "Worst possible pain". 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT02143960 - VelaShape III Device in Comparison to Cryolipolysis for Circumferential Reduction N/A
Active, not recruiting NCT01976247 - A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction N/A
Completed NCT02154113 - Ultrashape System in Combination With VelaShape II Device for Circumferential Reduction N/A
Completed NCT01239147 - Effects of Whole Grain on Weight Maintenance Phase 3
Recruiting NCT05973526 - Comparison of the Effects of Electric Current With Needles and Surface Electrodes on the Abdominal Contour of Women N/A
Terminated NCT05388617 - Study To Assess Radiofrequency Diathermocontraction Device For Muscle Stimulation And The Treatment Of Abdominal Fat N/A
Completed NCT01318343 - Analysis of CoolSculpting by Zeltiq for Non-Invasive Cooling of Abdominal Fat Using the eZ App Large Applicator N/A
Completed NCT03428243 - Long-term Follow-up Study of the truSculpt Radiofrequency Device for Circumferential Reduction
Completed NCT03811093 - Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss N/A
Recruiting NCT05779644 - Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus N/A